AG
BVS icon

Algert Global’s Bioventus BVS Stock Holding History

Algert Global’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
108,268
-5,275
-5% -$50.4K 0.01% 968
2026
Q1 		$1.04M Buy
113,543
+17,592
+18% +$148K 0.02% 859
2025
Q4 		$714K Buy
95,951
+71,251
+288% +$512K 0.01% 897
2025
Q3 		$165K Sell
24,700
-94,293
-79% -$654K ﹤0.01% 1054
2025
Q2 		$788K Buy
118,993
+28,892
+32% +$205K 0.02% 854
2025
Q1 		$824K Buy
90,101
+23,081
+34% +$231K 0.02% 811
2024
Q4 		$704K Buy
+67,020
New +$793K 0.02% 857

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Algert Global's BVS Position: Q2 2026 in Review

Algert Global reduced its Bioventus (BVS) stake by 4.6% in Q2 2026, selling an estimated $50.4K and leaving 108,268 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #968.

Algert Global first reported a position in BVS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.04M in Q1 2026. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Algert Global held 108,268 shares of Bioventus worth $1.02M as of Q2 2026.
  • Algert Global sold 5,275 Bioventus shares in Q2 2026, an estimated $50.4K.
  • Bioventus made up 0.01% of Algert Global's portfolio in Q2 2026, its #968 holding.
  • Algert Global first reported a position in Bioventus in Q4 2024 and has held it in 7 quarters since.
  • Algert Global's Bioventus position peaked at $1.04M in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.